XML 71 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
Goodwill and Other Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of goodwill
Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):
 
CHCA
 
CHCI
 
RX
 
Specialty Sciences
 
Other
 
Total
Balance at June 27, 2015
$
1,817.2

 
$
1,530.2

 
$
1,086.0

 
$
199.6

 
$
88.2

 
$
4,721.2

Business acquisitions
9.7

 
87.4

 
—

 
—

 
—

 
97.1

Changes in assets held-for-sale
(13.0
)
 
—

 
—

 
—

 
(14.6
)
 
(27.6
)
Currency translation adjustments
(0.8
)
 
(53.3
)
 
(1.9
)
 
—

 
(2.1
)
 
(58.1
)
Purchase accounting adjustments
1.2

 
418.9

 
—

 
—

 
—

 
420.1

Balance at December 31, 2015
1,814.3

 
1,983.2

 
1,084.1

 
199.6

 
71.5

 
5,152.7

Business acquisitions
—

 
—

 
1.7

 
—

 
—

 
1.7

Changes in assets held-for-sale
4.5

 
—

 
—

 
—

 
9.0

 
13.5

Impairments
(24.5
)
 
(868.4
)
 
—

 
(199.6
)
 
—

 
(1,092.5
)
Currency translation adjustments
(0.9
)
 
(27.5
)
 
0.8

 
—

 
0.9

 
(26.7
)
Purchase accounting adjustments
17.2

 
(16.5
)
 
—

 
—

 
—

 
0.7

Balance at December 31, 2016
1,810.6

 
1,070.8

 
1,086.6

 
—

 
81.4

 
4,049.4

Re-allocation of goodwill(1)
35.3

 
—

 
27.7

 
—

 
(63.0
)
 
—

Business divestitures
—

 
(4.1
)
 
—

 
—

 
(26.4
)
 
(30.5
)
Currency translation adjustments
1.5

 
139.0

 
8.0

 
—

 
8.0

 
156.5

Balance at December 31, 2017
$
1,847.4

 
$
1,205.7

 
$
1,122.3

 
$
—

 
$
—

 
$
4,175.4



(1) Certain cash flow associated with the API business were retained. We performed a relative fair value allocation of the business retained and allocated it among the two segments where the business was allocated.
These reporting units had the following remaining goodwill balances as of December 31, 2017 (in millions):
Reporting Unit
 
Goodwill Remaining in Reporting Unit
 
Segment
 
Fair Value in excess of Carrying Value
BCH
 
$
1,026.0

 
CHCI
 
6.6%
Animal Health
 
$
178.9

 
CHCA
 
23.6%
UK AUS
 
$
53.1

 
CHCI
 
18.3%
Schedule of finite and indefinite-lived intangible assets
Other intangible assets and the related accumulated amortization consisted of the following (in millions):
 
December 31, 2017
 
December 31, 2016
 
December 31, 2015
 
Gross
 
Accumulated
Amortization
 
Gross
 
Accumulated
Amortization
 
Gross
 
Accumulated Amortization
Definite-lived intangibles:
 
 
 
 
 
 
 
 
 
 
 
Distribution and license agreements, supply agreements
$
311.2

 
$
169.8

 
$
305.6

 
$
120.4

 
$
242.4

 
$
77.7

Developed product technology, formulations, and product rights
1,358.4

 
598.7

 
1,418.1

 
526.0

 
1,387.6

 
426.0

Customer relationships and distribution networks
1,642.0

 
460.6

 
1,489.9

 
307.5

 
1,520.7

 
193.0

Trademarks, trade names, and brands
1,335.4

 
129.5

 
1,189.3

 
55.3

 
539.4

 
22.8

Non-compete agreements
14.7

 
12.6

 
14.3

 
11.2

 
15.2

 
12.7

Total definite-lived intangibles
$
4,661.7

 
$
1,371.2

 
$
4,417.2

 
$
1,020.4

 
$
3,705.3

 
$
732.2

Indefinite-lived intangibles:
 
 
 
 
 
 
 
 
 
 
 
Trademarks, trade names, and brands
$
52.1

 
$
—

 
$
50.5

 
$
—

 
$
1,868.1

 
$
—

In-process research and development
38.2

 
—

 
64.0

 
—

 
48.2

 
—

Total indefinite-lived intangibles
$
90.3

 
$
—

 
$
114.5

 
$
—

 
$
1,916.3

 
$
—

Total other intangible assets
$
4,752.0

 
$
1,371.2

 
$
4,531.7

 
$
1,020.4

 
$
5,621.6

 
$
732.2
Schedule of Intangible Assets Impairment
Intangible asset impairments taken are as follows (in millions):
 
Year Ended
 
Six Months Ended
 
December 31, 2017
 
December 31, 2016
 
December 31, 2015
 
Definite-Lived Intangible Assets
 
IPR&D
 
Indefinite-Lived Intangible Assets
 
Definite-Lived Intangible Assets
 
IPR&D
 
Indefinite-Lived Intangible Assets
CHCA
$
—

 
$
—

 
$
0.4

 
$
—

 
$
—

 
$
—

CHCI
—

 
1.1

 
849.1

 
321.4

 
3.5

 
185.1

RX
19.7

 
11.6

 
—

 
342.2

 
—

 
—

Other
—

 
—

 
—

 
2.0

 
—

 
—

 
$
19.7

 
$
12.7

 
$
849.5

 
$
665.6

 
$
3.5

 
$
185.1
Schedule of acquired finite-lived intangible assets by major class
The remaining weighted-average useful life for our amortizable intangible assets by asset class at December 31, 2017 was as follows:
Amortizable Intangible Asset Category
 
Remaining Weighted-Average Useful Life (Years)
Distribution and license agreements, supply agreements
 
7
Developed product technology, formulations, and product rights
 
12
Customer relationships and distribution networks
 
17
Trademarks, trade names, and brands
 
20
Non-compete agreements
 
2
Schedule of finite-lived intangible assets, future amortization expense
Our estimated future amortization expense is as follows (in millions):
Year
 
Amount
2018
 
$
341.0

2019
 
316.4

2020
 
280.8

2021
 
251.8

2022
 
222.0

Thereafter
 
1,878.5